Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update

With recent FDA acceptance of the Phase 2a multidose portion of INLIGHT trial of WVE-007 (INHBE GalNAc-siRNA) in individuals with higher BMI, ...

Could this small-town state lawmaker defeat a sitting congressman?

Former state representative Craig Haggard believes he can, though little precedent exists for a primary upset in the deep-red ...
Healio

Q&A: Palforzia’s discontinuation ‘disappointing,’ but new options may be forthcoming

Commercialization of Palforzia, the first FDA-approved peanut allergy oral immunotherapy, will be discontinued at the end of ...
AccessWDUN

UPS Releases 1Q 2026 Earnings

UPS Releases 1Q 2026 EarningsThe Associated PressATLANTA ATLANTA–(BUSINESS WIRE)–Apr 28, 2026– UPS (NYSE:UPS) today announced first-quarter 2026 consolidated revenues of $21.2 billion. Consolidated ...